{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:03:08Z","timestamp":1778054588032,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1986,10,1]],"date-time":"1986-10-01T00:00:00Z","timestamp":528508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1986,10]]},"DOI":"10.1007\/bf01806246","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T00:10:09Z","timestamp":1119917409000},"page":"161-169","source":"Crossref","is-referenced-by-count":105,"title":["Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer"],"prefix":"10.1007","volume":"7","author":[{"given":"Rosella","family":"Silvestrini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Daidone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Fronzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinuccia","family":"Valagussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianni","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01806246_CR1","first-page":"141","volume-title":"Breast Cancer: Diagnosis and Management, Vol 1","author":"JF Stewart","year":"1984","unstructured":"Stewart JF, Rubens RD: General prognostic factors. In: Bonadonna G (ed): Breast Cancer: Diagnosis and Management, Vol 1. Wiley, New York, 1984, pp. 141\u2013168"},{"key":"BF01806246_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/978-3-642-82357-2_5","volume":"96","author":"G Bonadonna","year":"1984","unstructured":"Bonadonna G, Valagussa P: Contribution of prognostic factors to adjuvant chemotherapy in breast cancer. Recent Results Cancer Res 96: 34\u201345, 1984","journal-title":"Recent Results Cancer Res"},{"key":"BF01806246_CR3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0014-2964(79)90094-X","volume":"15","author":"P Valagussa","year":"1977","unstructured":"Valagussa P, Brambilla C, Bonadonna G: Advanced breast cancer: Are the traditional stratification parameters still of value when patients are treated with combination chemo-therapy? Eur J Cancer 15: 565\u2013571, 1977","journal-title":"Eur J Cancer"},{"key":"BF01806246_CR4","first-page":"1551","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher B, Bauer M, Wickerham DL et al.: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551\u20131557, 1983","journal-title":"An NSABP update. Cancer"},{"key":"BF01806246_CR5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/1097-0142(196911)24:5<1071::AID-CNCR2820240533>3.0.CO;2-H","volume":"24","author":"B Fisher","year":"1969","unstructured":"Fisher B, Slack NH, Bross IDJ et al.: Cancer of the breast: Size of neoplasm and prognosis. Cancer 24: 1071\u20131080, 1969","journal-title":"Cancer"},{"key":"BF01806246_CR6","first-page":"4292","volume":"38","author":"PV Maynard","year":"1978","unstructured":"Maynard PV, Blamey RW, Elston JW, Haybittle JL, Griffiths K: Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res 38: 4292\u20134295, 1978","journal-title":"Cancer Res"},{"key":"BF01806246_CR7","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U","volume":"46","author":"CK Osborne","year":"1980","unstructured":"Osborne CK, Yochmowitz MG, Knight WA III, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884\u20132888, 1980","journal-title":"Cancer"},{"key":"BF01806246_CR8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/bmj.283.6302.1289","volume":"283","author":"R Croton","year":"1981","unstructured":"Croton R, Cooke T, Holt S, George WD, Nicolson R, Griffiths K: Oestrogen receptors and survival in early breast cancer. Br Med J 283: 1289\u20131291, 1981","journal-title":"Br Med J"},{"key":"BF01806246_CR9","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/1097-0142(19840601)53:11<2525::AID-CNCR2820531126>3.0.CO;2-8","volume":"53","author":"S Aamdal","year":"1984","unstructured":"Aamdal S, Bormer O, Jorgensen O, Host H, Eliassen G, Kaalhus O, Pihl A: Estrogen receptors and long-term prognosis in breast cancer. Cancer 53: 2525\u20132529, 1984","journal-title":"Cancer"},{"key":"BF01806246_CR10","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(19841115)54:10<2237::AID-CNCR2820541029>3.0.CO;2-V","volume":"54","author":"FF Parl","year":"1984","unstructured":"Parl FF, Schmidt BP, Dupont WD, Wagner RK: Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading. Cancer 54: 2237\u20132242, 1984","journal-title":"Cancer"},{"key":"BF01806246_CR11","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/1097-0142(19850315)55:6<1178::AID-CNCR2820550606>3.0.CO;2-U","volume":"55","author":"JA Butler","year":"1985","unstructured":"Butler JA, Bretsky S, Menendez-Botet C, Kinne DW: Estrogen receptor protein of breast cancer as a predictor of recurrence. Cancer 55: 1178\u20131181, 1985","journal-title":"Cancer"},{"key":"BF01806246_CR12","first-page":"447","volume":"22","author":"A Bertuzzi","year":"1981","unstructured":"Bertuzzi A, Vezzoni P, Ronchi E: Prognostic importance of progesterone receptors alone or in combination with estrogen receptors in node negative breast carcinoma (Abstr). Proc Am Soc Clin Oncol 22: 447, 1981","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF01806246_CR13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM198312013092240","volume":"309","author":"GM Clark","year":"1983","unstructured":"Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS: Progesterone receptor as a prognostic factor in stage II breast cancer. N Engl J Med 309: 1343\u20131347, 1983","journal-title":"N Engl J Med"},{"key":"BF01806246_CR14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/bjc.1984.234","volume":"50","author":"A Alanko","year":"1984","unstructured":"Alanko A, Heinonen E, Scheinin TM, Tolppanen EM, Vihko R: Oestrogen and progesterone receptors and disease-free interval in primary breast cancer. Br J Cancer 50: 667\u2013672, 1984","journal-title":"Br J Cancer"},{"key":"BF01806246_CR15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/1097-0142(19810815)48:4<974::AID-CNCR2820480420>3.0.CO;2-#","volume":"48","author":"C Gentili","year":"1981","unstructured":"Gentili C, Sanfilippo O, Silvestrini R: Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer 48: 974\u2013979, 1981","journal-title":"Cancer"},{"key":"BF01806246_CR16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1097-0142(19830515)51:10<1879::AID-CNCR2820511021>3.0.CO;2-9","volume":"51","author":"JS Meyer","year":"1983","unstructured":"Meyer JS, Friedman E, McCrate MM, Bauer WC: Prediction of early course of breast carcinoma by thymidine labeling. Cancer 51: 1879\u20131886, 1983","journal-title":"Cancer"},{"key":"BF01806246_CR17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ijc.2910330404","volume":"33","author":"M Tubiana","year":"1984","unstructured":"Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP: The long-term prognostic significance of the thymidine labeling index in breast cancer. Int J Cancer 33: 441\u2013445, 1984","journal-title":"Int J Cancer"},{"key":"BF01806246_CR18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2964(73)90055-8","volume":"9","author":"EORTC Breast Cancer Cooperative Group","year":"1973","unstructured":"EORTC Breast Cancer Cooperative Group: Standards for the assessment of estrogen receptors in human breast cancer. Eur J Cancer 9: 379\u2013381, 1973","journal-title":"Eur J Cancer"},{"key":"BF01806246_CR19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","volume":"51","author":"G Scatchard","year":"1949","unstructured":"Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 600\u2013672, 1949","journal-title":"Ann NY Acad Sci"},{"key":"BF01806246_CR20","volume-title":"Statistical Methods for Rates and Proportion","author":"JL Fleiss","year":"1973","unstructured":"Fleiss JL: Statistical Methods for Rates and Proportion. Wiley, New York, 1973"},{"key":"BF01806246_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P et al.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Analysis and examples. Br J Cancer 35: 1\u201339, 1977","journal-title":"Br J Cancer"},{"key":"BF01806246_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR: Regression models and life table (with discussion). J Roy Stat Soc (B) 34: 187\u2013220, 1972","journal-title":"J Roy Stat Soc (B)"},{"key":"BF01806246_CR23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01806265","volume":"1","author":"A Bertuzzi","year":"1981","unstructured":"Bertuzzi A, Daidone MG, Di Fronzo G, Silvestrini R: Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. Breast Cancer Res Treat 1: 253\u2013262, 1981","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806246_CR24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/1097-0142(197803)41:3<1170::AID-CNCR2820410355>3.0.CO;2-I","volume":"41","author":"P Valagussa","year":"1978","unstructured":"Valagussa P, Bonadonna G, Veronesi U: Pattern of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41: 1170\u20131178, 1978","journal-title":"Cancer"},{"key":"BF01806246_CR25","first-page":"528","volume":"140","author":"B Fisher","year":"1975","unstructured":"Fisher B, Slack N, Katrych DL, Wolmark N: Ten-year follow-up of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 140: 528\u2013534, 1975","journal-title":"Surg Gynecol Obstet"},{"key":"BF01806246_CR26","first-page":"407","volume-title":"Adjuvant Therapy of Cancer IV","author":"P Valagussa","year":"1984","unstructured":"Valagussa P, Bignami P, Buzzoni R et al.: Are estrogen receptors alone a reliable prognostic factor in node negative breast cancer? In: Jones SE, Salmon SE (eds): Adjuvant Therapy of Cancer IV. Grune and Stratton, New York, 1984, pp 407\u2013415"},{"key":"BF01806246_CR27","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/1097-0142(19851015)56:8<1982::AID-CNCR2820560816>3.0.CO;2-I","volume":"56","author":"R Silvestrini","year":"1985","unstructured":"Silvestrini R, Daidone MG, Gasparini G: Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer 56: 1982\u20131987, 1985","journal-title":"Cancer"},{"key":"BF01806246_CR28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/bjc.1985.138","volume":"51","author":"MR Williams","year":"1985","unstructured":"Williams MR, Nicholson RI, Elston CW, Todd J, Griffiths K, Blamey RW: Oestrogen receptors in primary breast cancer. Br J Cancer 51: 907\u2013909, 1985","journal-title":"Br J Cancer"},{"key":"BF01806246_CR29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01806024","volume":"5","author":"HO Adami","year":"1985","unstructured":"Adami HO, Graffman S, Lindgren A, Sallstrom J: Prognostic implication of estrogen receptor content in breast cancer. Breast Cancer Res Treat 5: 293\u2013300, 1985","journal-title":"Breast Cancer Res Treat"},{"key":"BF01806246_CR30","first-page":"445","volume":"68","author":"MM Black","year":"1982","unstructured":"Black MM, Hankey BF, Barclay THC: Intrastage prognostic heterogeneity: implications for adjuvant chemotherapy of breast cancer. J Natl Cancer Inst 68: 445\u2013447, 1982","journal-title":"J Natl Cancer Inst"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01806246\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01806246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:01:44Z","timestamp":1735776104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01806246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,10]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1986,10]]}},"alternative-id":["BF01806246"],"URL":"https:\/\/doi.org\/10.1007\/bf01806246","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,10]]}}}